Introduction {#s1}
============

Dengue viruses cause clinical disease in approximately 100 million individuals each year and are found in over 100 countries ([@bib10]). Yet, to date no vaccine exists that conveys cross-protection against all human dengue viruses ([@bib77]). Dengue viruses are positive sense RNA viruses in the family *Flaviviridae,* and are related to yellow fever virus, Zika virus, and West Nile virus ([@bib8]). These viruses are primarily transmitted between humans in highly populated areas by *Aedes aegypti* and *Aedes albopictus* mosquitoes, in what are referred to as human (or 'urban') transmission cycles ([@bib21]; [@bib31]; [@bib86]). Sylvatic (i.e. forest) dengue virus transmission cycles, which are separate from the human transmission cycles, exist in Asia and Africa and involve nonhuman primates and forest-dwelling *Aedes* mosquitos ([@bib86]; [@bib92]; [@bib68]). While the exact nonhuman primate species that serve as the sustaining natural reservoirs for sylvatic dengue viruses are unknown, the global distribution of both dengue viruses and their transmitting mosquitoes could be consistent with a significant number of primate species being involved ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}) ([@bib31]; [@bib86]). Primarily, dengue viruses have been associated with monkeys (rather than apes) found in Africa and Asia ([Figure 1](#fig1){ref-type="fig"}). Human dengue viruses cluster into four phylogenetically distinct clades referred to as DENV1, 2, 3, and 4 ([@bib90]). These clades have sylvatic dengue virus isolates at their bases, supporting zoonotic origins of the four dengue viruses that now circulate in humans ([@bib92]; [@bib66]; [@bib93]). Human dengue viruses have now become uncoupled from the sylvatic reservoir and require only humans and mosquitoes to be sustained ([@bib47]).

![Dengue virus (DENV2) can cleave human but not nonhuman primate STING.\
(**A**) A phylogeny of select primate species, showing the three main simian clades: apes, Old World monkeys, and New World monkeys ([@bib62]). The primate species from which STING is tested in this study are shown with purple arrows. Possible primate reservoir hosts for sylvatic dengue viruses, based on virus isolation from sentinel monkeys, or antibody detection, are shown in red (Africa) and green (Asia). The current evidence for these primate reservoir hosts is reviewed in the discussion section. (**B**) 293T cells were cotransfected with plasmids encoding STING-HA, and the NS2B3-Flag protease complex with or without the S135 inactivating mutation. Whole cell lysate isolated 24 hr post transfection was run on a protein gel and immunoblotted with anti-Flag or anti-HA antibodies. The encoded NS2B-NS3-Flag polyprotein auto-processes into the NS2B3 protease complex if the protease is active, as seen in the anti-Flag blot where in some samples the NS3-Flag protein has been liberated through cleavage. We sometimes see lower bands underneath the full-length mouse STING, but conclude that they are endogenous degradation products since they are equal in intensity in the presence of the active or dead protease.](elife-31919-fig1){#fig1}

In side-by-side experiments, sylvatic and human dengue viruses replicate similarly in human cells ([@bib89]; [@bib88]). These results have been interpreted to mean that there is little or no adaptive barrier for the emergence of sylvatic dengue viruses into human populations, and the view that dengue viruses are generalists capable of infecting a wide range of primate species including humans. Thus, a paradox exists in understanding why human dengue viruses are so difficult to model in nonhuman primates. Chimpanzees (*Pan troglodytes*) ([@bib76]), rhesus macaques (*Macaca mulatta*) ([@bib30]; [@bib33]), marmosets (multiple *Callithrix* species) ([@bib54]; [@bib25]), and other nonhuman primate species ([@bib4]) have been explored as possible primate models for studying dengue virus pathogenesis and for vaccine challenge. In general, it has been observed that dengue does not replicate to high titers in these models, and little or no overt disease pathology is observed ([@bib15]; [@bib101]). If human and sylvatic viruses are the same in their properties, we speculated that there must instead be something special about the replication of these viruses in the human host.

STING is a multi-pass transmembrane protein found in the endoplasmic reticulum, and functions as a critical component in the innate immune sensing pathway for intracellular pathogens ([@bib36]; [@bib100]; [@bib37]; [@bib38]; [@bib84]; [@bib11]). Although originally described as part of the response to cytosolic DNA sensing ([@bib99]), STING is also activated upon RNA virus infection ([@bib34]). Underscoring this, several RNA viruses encode proteins that antagonize or degrade STING ([@bib83]; [@bib59]; [@bib22]; [@bib3]; [@bib96]). For instance, the NS2B3 protease of one human dengue virus, DENV2, has been shown to target human STING for cleavage ([@bib3]; [@bib96]). Through the cleavage of STING, DENV2 renders the host unable to induce the phosphorylation of Interferon Regulatory Factor 3 (IRF3), therefore decreasing production of type I interferon and increasing viral titers ([@bib29]). Mouse STING is resistant to cleavage by the DENV2 protease ([@bib3]; [@bib96]). This at least partially explains why mice mount an effective immune response against dengue viruses, protecting them against infection and compromising their utility as model organisms ([@bib15]; [@bib101]; [@bib6]). Dengue viruses are known to mute the host interferon response in other ways as well, with the other predominant mechanism being the degradation of STAT2 ([@bib5]; [@bib39]; [@bib48]; [@bib9]; [@bib55]).

In this study, we show that the NS2B3 proteases of human (DENV1-4) and sylvatic dengue viruses universally cleave human STING. However, none of these proteases can cleave the STING proteins of chimpanzees, macaques, or marmosets, three primate species that have been pursued as model organisms. We show that an 'RG' motif at positions 78/79 of STING is critical for susceptibility to cleavage, and conversion of these residues to 'RG' renders all nonhuman primate STING proteins tested, as well as mouse STING, sensitive to dengue virus proteases. Out of the entire Genbank database, along with our sequencing of STING from 16 additional primate species, we identify only a small number of apes (gorillas, orangutans, and gibbons), and three small rodent species (chinchillas, naked mole rats, and desert woodrats) as encoding a functional dengue virus cleavage determinant in STING. This may, in part, explain why modeling dengue virus in animal models has been so difficult.

Results {#s2}
=======

The protease of human dengue virus, DENV2, cleaves only human STING {#s2-1}
-------------------------------------------------------------------

To begin, we cloned STING from chimpanzee (*Pan troglodytes*, Genbank XM_016953921), rhesus macaque (*Macaca mulatta*, Genbank MF622060), and the common marmoset (*Callithrix jacchus*, Genbank MF622061). These species have been explored as animal models of dengue infection, and also represent the three major clades of simian primates: apes (represented by chimpanzee), Old World monkeys (represented by macaque), and New World monkeys (represented by marmoset; [Figure 1A](#fig1){ref-type="fig"}). Most suspected dengue virus reservoir hosts belong to the Old World monkey clade (red and green type in [Figure 1A](#fig1){ref-type="fig"}). On the other hand, New World monkeys (such as marmosets), which reside exclusively in the Americas, have presumably never been exposed to sylvatic dengue viruses since sylvatic cycles do not exist in the New World. We also included human (Genbank MF622062) and mouse (*Mus musculus*, Genbank MF622063) STING in our studies as positive and negative controls, since it was previously shown that human but not mouse STING is sensitive to DENV2 NS2B3 cleavage ([@bib3]; [@bib96]).

The dengue virus NS2B3 protease complex is composed of the viral non-structural proteins NS2B and NS3 ([@bib65]; [@bib98]; [@bib24]). In the dengue virus genome, the NS2B and NS3 genes sit adjacent and are cotranslated as part of a single long viral polyprotein ([@bib63]; [@bib16]). When the NS2B - NS3 region is expressed from a plasmid, the region is translated into a small polyprotein that then auto-cleaves itself to become the functional protease complex ([@bib97]; [@bib7]). We used a plasmid expressing the NS2B-NS3 region, including a 3x Flag tag at the C-terminus of NS3, from the New Guinea C isolate of DENV2 (see methods). As a control, a mutation was created at the active-site serine, changing it to an alanine (S135A), which renders the protease inactive ([@bib70]). We then used a previously established cotransfection assay ([@bib3]; [@bib96]) to determine if the dengue virus protease could cleave primate STING orthologs. Plasmids encoding primate or mouse STING, and either active or S135A (dead) NS2B3 dengue proteases, were cotransfected into 293T cells. STING cleavage was assessed 24 hr later by western blot. The inactivity of the S135A protease can be seen in the anti-Flag blot, where the NS2B-NS3 polyprotein does not self-cleave when this mutation is present ([Figure 1B](#fig1){ref-type="fig"}). We see only a fraction of the human STING being cleaved, but this is consistent with previous publications and is presumably exacerbated by the overexpression of STING achieved in transfection experiments ([@bib3]; [@bib96]). Unexpectedly, none of the nonhuman primate STINGs tested were susceptible to cleavage ([Figure 1B](#fig1){ref-type="fig"}). Remarkably, the DENV2 protease could not even cleave chimpanzee STING, which differs from human STING at only three amino acid positions.

Mapping the dengue virus cleavage determinants in STING {#s2-2}
-------------------------------------------------------

The dengue virus cleavage site in STING was previously mapped to between the 95th and 96th residues ([@bib3]; [@bib96]). Some uncertainty existed, though, because in the previous studies it was noted that the human residues around 95/96 were not sufficient to convey cleavage susceptibility to mouse STING. Indeed, human and chimpanzee STING proteins have the exact same amino acid sequence at these positions ([Figure 2A](#fig2){ref-type="fig"}). Human and chimpanzee STING differ at only three amino acid positions, residues 78, 230, and 232. We found that mutating the human STING to encode the chimpanzee residue at site 78 (78W) caused it to become resistant to cleavage by DENV NS2B3 ([Figure 2B](#fig2){ref-type="fig"}). Likewise, mutating the chimpanzee STING at residue 78 to the human amino acid (78R) rendered the chimpanzee STING susceptible to cleavage ([Figure 2B](#fig2){ref-type="fig"}). We saw no effect of mutations at a second site, 230, either alone or in combination with residue 78 ([Figure 2B](#fig2){ref-type="fig"}). Previously, it had been shown that STING site 78 may be important for retention in the endoplasmic reticulum (ER) ([@bib84]). To ensure that ER retention was not disrupted by the mutations that we tested, we disrupted both copies of STING in A549 cells using CRISPR-Cas9 targeting, and then stably re-complemented them with wildtype or 78W (cleavage resistant) human STING ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Both the wildtype and mutant STING similarly localized to the ER ([Figure 2---figure supplement 2](#fig2s2){ref-type="fig"}). It is logical that the 78W substitution would not affect ER-localization of STING, since 78W is naturally occurring in the chimpanzee STING protein. Therefore, we can conclude that position 78R is a critical determinant for dengue virus cleavage, either as a binding site or a cleavage site for the dengue protease. It was previously estimated that STING is cleaved in a way that divides the protein into approximately 25% and 75% of its original molecular weight, with the N-terminus of the protein representing the smaller portion ([@bib96]). This would place the cleavage site in the vicinity of the 78th residue. In addition, the 78/79 'RG' motif is in good agreement with what is known about the preferences of NS2B3, where glycine (G) often lies directly downstream of the peptide cleavage site, and an arginine (R) directly upstream ([@bib42]).

![STING residue 78 determines susceptibility to NS2B3 cleavage in human versus chimpanzee STING comparisons.\
(**A**) A domain diagram of human STING is shown, as defined in ([@bib95]). An alignment of human and chimpanzee STING in the region of the newly identified cleavage determinant (78/79) and the one previously determined (95/96) ([@bib3]; [@bib96]). (**B**) Site-directed mutagenesis was performed on either human or chimpanzee STING at position 78, substituting the residue at this position in human (R) with that in chimpanzee (W) and vice versa. Plasmids encoding the NSB3 protease complex and STING were cotransfected into 293T cells, and 48 hr later lysates were collected and analyzed by anti-FLAG western blot. In this experiment, both the protease and STING are tagged with FLAG. Data presented are representative of at least two experiments. (**C**) (bottom) 293T cells were transfected with plasmids expressing the DENV2 NS2B3 protease and wildtype (wt) or mutated (78W or 78R) STING. IRF3 and phosphorylated IRF3 (pIRF3) were detected by western blot in lysates harvested 48 hr later. (top) The identical experiment, but performed in biological triplicate and with the addition of plasmids encoding a firefly luciferase gene driven by the interferon beta (IFNb) promoter, and a renilla luciferase gene driven by a CMV promoter. The relative luciferase activity (Y-axis) was calculated by normalizing the luciferase signal to the renilla signal in each replicate. A Welch's T-test was used to compare the levels of luciferase produced in the presence of active versus dead protease. Data is representative of at least two experiments.](elife-31919-fig2){#fig2}

Next we wished to ensure that the cleavage of STING alters its ability to signal in the interferon induction pathway. Transfection of plasmids encoding STING into cells is sufficient to activate the interferon induction pathway ([@bib36]). We again performed cotransfection of plasmids encoding STING and the dengue virus protease. 48 hr after transfection, cell lysates were probed in western blots for phosphorylated IRF3 (pIRF3) and for total IRF3. We found that pIRF3 was reduced when human or chimpanzee STING was susceptible to NS2B3 cleavage, and not reduced when STING was resistant to cleavage ([Figure 2C](#fig2){ref-type="fig"}, bottom). We also monitored the activation of the interferon-beta (IFNb) promoter. We performed an identical cotransfection assay with plasmids encoding STING and NS2B3, only in triplicate, and with two additional plasmids: one encoding a firefly luciferase reporter gene downstream of the IFNb promoter, and another encoding a renilla luciferase reporter gene downstream of a CMV promoter (used to normalize transfection efficiencies between samples, by taking the ratio of firefly:renilla luciferase). With human STING and the version of chimpanzee STING rendered sensitive to cleavage (78R), there was a significant reduction in firefly luciferase production in the presence of active NS2B3, in comparison to the catalytically dead version of the protease ([Figure 2C](#fig2){ref-type="fig"}, top). This reduction is not observed with chimpanzee STING, or with human STING rendered resistant to cleavage by the 78W mutation.

We then verified these results with infection experiments. We stably re-complemented our A549 STING knockout cells, using retroviral transduction, to express various forms of STING: chimpanzee or human 78W (both cleavage resistant), human or chimpanzee 78R (both cleavage susceptible), or cells were complemented with an empty vector ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). These cells were infected with dengue virus 2 (strain 16681) at MOI 0.3. At 24 and 48 hr post infection, supernatant was harvested and viral content was quantified by plaque assay on BHK21 cells, and at the same time cells were harvested and lysed for western blot. We found that A549 cells re-complemented with STING, regardless of the version, produced less dengue virus than the STING knockout cell line that was not re-complemented ([Figure 3](#fig3){ref-type="fig"}). However, cells re-complemented with a cleavage-resistant STING produced less virus than those re-complemented with a cleavage-susceptible STING ([Figure 3](#fig3){ref-type="fig"}). In fact, cell lines in this experiment that differ by only a single amino acid in STING demonstrate as much as a 176-fold change in infectious virus produced at 24 hr post-infection, according to the titration experiments (human versus human 78W STING). The difference remains significant at 48 hr post-infection. This suggests that cleavage of STING is critically important for dengue virus replication, and has a large impact on viral titers. The STING cleavage product was not visible in the western blots performed during these experiments. This cleavage product is typically only detectable when cells are treated with MG132 proteasome inhibitor for several hours before cell lysis. While our transfection-based cleavage assays typically incorporate MG132 treatment (see Materials and methods), it was not used in the infection experiments shown here in order to not perturb infectious virus produced. In a separate experiment performed in the presence of MG132, we do see the cleavage of STING during infections ([Figure 3---figure supplement 1](#fig3s1){ref-type="fig"}). Further, the cleavage of endogenous STING during dengue infection was previously demonstrated under other conditions ([@bib3]; [@bib96]).

![Cleavage of STING at position 78/79 promotes virus replication.\
The endogenous copies of STING in A549 cells were knocked out using the Cas9 nuclease (see [Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). These cells were re-complemented by retroviral transduction with no gene (pLPCX-empty), wildtype human STING, cleavage-resistant human STING (human 78W), wildtype chimpanzee STING, or cleavage-susceptible chimpanzee STING (chimp 78R). These cell lines were infected at MOI of 0.3 with dengue virus 2 (DENV2 16681). After 24 and 48 hr the virus supernatant was removed and titrated on BHK21 cells. At the same time, cells were collected in RIPA buffer, lysed, and run on a gel for western blotting using antibodies against STING, dengue virus NS3, and GAPDH (loading control). A Tukey\'s multiple comparisons test indicated significant differences in infectious virus in the presence of each mutant STING compared to wildtype STING, as shown (\*\*\*\*=p \< 0.0001), after significant one-way ANOVA. Data are representative of at least two independent experiments.](elife-31919-fig3){#fig3}

We next wanted to determine if our newly identified cleavage determinant could explain the resistance to STING cleavage seen in other species. The dengue protease also cannot cleave rhesus macaque, marmoset, or mouse STING ([Figure 1B](#fig1){ref-type="fig"}), all of which deviate from the 'RG' motif found in human STING (highlighted green in [Figure 4A](#fig4){ref-type="fig"}). We next performed site-directed mutagenesis to alter either the 78th or 79th residue in STING of these species. We found that, in all cases, mutations that restored this motif to the human 'RG' restored susceptibility to cleavage ([Figure 4B](#fig4){ref-type="fig"}). Consistent with previous studies ([@bib3]; [@bib96]), mutation of residues 93--96 in mouse STING to match the human 'LRRG' did not confer susceptibility to cleavage by NS2B3 ([Figure 4B](#fig4){ref-type="fig"}). Overall, these results further support the conclusion that sites 78 and 79 are critical determinants for cleavage by the DENV NS2B3 protease. An 'RG' motif at these two positions is both necessary and sufficient to make primate and rodent STING susceptible to cleavage by the DENV2 protease.

![Residues 78 and 79 of STING define a dengue virus cleavage determinant in both primate and mouse STING.\
(**A**) A phylogeny and multiple sequence alignment of STING from various primate species and mouse. Shown in green is the 78/79 motif in STING that is mutated in panel B. Shown in red is the motif changed in mouse STING, only, in panel B. (**B**) Site directed mutagenesis was performed on human, rhesus macaque, marmoset, or mouse STING at sites 78/79 or 93--96 (mouse only). 293T cells were cotransfected with mammalian expression plasmids encoding STING along with wildtype or mutant NS2B3. 24 hr after transfection, whole-cell lysate was harvested and probed for FLAG or HA by western blot. Data presented are representative of at least two experiments.](elife-31919-fig4){#fig4}

The 78--79 RG motif in STING is a universal cleavage determinant for the proteases of human and sylvatic dengue viruses {#s2-3}
-----------------------------------------------------------------------------------------------------------------------

To test whether these results are generalizable to other dengue viruses endemic in humans, we cloned the region encoding the NS2B3 protease complex from three additional DENV isolates (one from each endemic human virus): DENV1 (Hawaii), DENV3 (Philippines/H887/1956), and DENV4 (H241). While some of these proteases expressed better than others, all were able to cleave wildtype human STING far more efficiently than human STING bearing the 78W mutation ([Figure 5A](#fig5){ref-type="fig"}). This data indicates that the 78/79 RG motif of STING is recognized (i.e. bound or cleaved) by the NS2B3 proteases of all endemic human dengue viruses. If residues 78/79 in fact constitute the actual cleavage site for the protease, this would be in line with biochemical studies showing that the proteases of all four endemic human dengue viruses have similar cleavage motif preferences ([@bib42]).

![The 78/79 cleavage determinant in STING is targeted by proteases encoded by all endemic human dengue viruses, and by at least one sylvatic dengue virus.\
(**A**) 293T cells were cotransfected with plasmids encoding NS2B3 from DENV1-4 along with human STING with or without a mutation at site 78. Western blotting was performed on lysate harvested 24 hr post transfection to detect NS2B3 (anti-FLAG) or STING (anti-HA). Data presented are representative of at least two experiments. (**B**) 293T cells were cotransfected with plasmids encoding the indicated STING and the NS2B3 from a sylvatic isolate of dengue virus (DakAr-141069). 24 hr post transfection, lysates where harvested, run on a gel, and western blotting was performed with an anti-HA antibody to detect STING. All data presented are representative of at least two experiments.](elife-31919-fig5){#fig5}

We next cloned the NS2B3 protease from a sylvatic dengue strain (DakAr-141069). This virus was first isolated from an *Ae. luteocephalus* mosquito in Senegal in 1999 ([@bib88]). We find that this viral protease also cleaves human STING, but not the STING of chimpanzee, rhesus macaque, or marmoset ([Figure 5B](#fig5){ref-type="fig"}). Further, the restoration of the 'RG' motif at positions 78/79 again renders all of these STING proteins susceptible to cleavage ([Figure 5B](#fig5){ref-type="fig"}), indicating that the sylvatic protease is targeting (i.e. binding or cleaving) the same cleavage determinant as the proteases from human dengue viruses. This is consistent with the high degree of similarity between human and sylvatic proteases, as can be seen in alignment of the two ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}).

It is curious to find that a sylvatic dengue virus does not cleave nonhuman primate STING. Since we don't know the exact species that constitute the viral reservoir, we next considered the question of whether any nonhuman primates encode the correct cleavage determinant at positions 78/79 in STING. To address this, we harvested mRNA from cell lines derived from 16 different nonhuman primate species (see Materials and methods). From these mRNA pools, we made cDNA libraries and sequenced the STING cDNA using Sanger sequencing. We also gathered STING sequence for 14 additional primate species from Genbank. An alignment of the eight amino acid region in STING surrounding the 78/79 cleavage determinant (downward arrow in [Figure 6A](#fig6){ref-type="fig"}) is shown for all 30 of these primate species (a full alignment of primate STING sequences is provided in [Supplementary file 1](#supp1){ref-type="supplementary-material"}). With the exception of chimpanzees and bonobos, all apes encode the same amino acids as human in this motif, constituting the correct cleavage determinant for dengue virus. In contrast, no monkey species encodes an 'RG' at positions 78/79. Instead, Old World monkeys all encode 'RD,' which is the same motif found in the macaque clone that we have tested. Also, no monkeys from the Americas encode an 'RG' at these residues, and instead these species encode a 'QG' at positions 78/79, just like the marmoset clone tested herein.

![The dengue virus cleavage determinant in STING of various species.\
(**A**) An alignment of the eight amino acid region in STING surrounding residues 78R/79G, the newly identified dengue virus cleavage determinant (downward arrow at top). Deviations from the human motif are highlighted. The green boxes indicate STING orthologs sequenced as part of this study. The brown boxes indicate STING sequences obtained from Genbank. Apes are shown at the top of the tree (pink type), monkeys at the bottom (green type). Depicted below are sequences from the same region of STING from two animal models for dengue virus (mouse, pig \[[@bib15]\]), several small rodent species which encode the correct cleavage motif at 78/79 (naked mole rat, common chinchilla, desert woodrat), and one that does not (13 lined ground squirrel). Genbank accession numbers of sequences shown: mouse (XP_017173483), pig (XP_005661761), 13-lined ground squirrel (XM_005327275), naked mole rat (JAO02071), chinchilla (XP_005382124), and desert woodrat (OBS58238). (**B**) STING-HA genes were synthesized for the rodent species discussed in panel A. Cleavage assays were performed by co-transfecting plasmids encoding the dengue protease (dead or active) as well as each STING, and then performing immunoblotting as described in the methods. The data presented are representative of at least two independent experiments.](elife-31919-fig6){#fig6}

Finally, we queried the entire Genbank database for STING sequences available from placental mammals. Mice and pigs, two current models for dengue virus infection ([@bib15]), also do not have the correct RG residues at STING 78/79 ([Figure 6A](#fig6){ref-type="fig"}). Out of the entire database, only two other mammals were identified that share the exact same sequence as humans in the eight amino acid region surrounding the newly identified dengue virus cleavage determinant in STING: chinchilla and naked mole rat, both of which are rodents ([Figure 6A](#fig6){ref-type="fig"}). A third rodent species, the desert woodrat, has the RG at positions 78/79, but encodes two amino acid substitutions just downstream of these residues, compared to human STING ([Figure 6A](#fig6){ref-type="fig"}). The fact that only a small handful of mammals encode an RG at position 78/79, out of the entire database, may in part explain why modeling dengue viruses in animals has been so difficult. We next wished to determine if STING is in fact cleaved by dengue in these rodent species, since all three already serve as animal models for biological research ([@bib40]; [@bib57]; [@bib78]; [@bib13]; [@bib80]). We synthesized HA-tagged STING genes for the rodent species discussed in [Figure 6A](#fig6){ref-type="fig"}, as well as an additional rodent (13-lined ground squirrel) which does not have the 'RG' motif at STING 78/79, as a negative control. Cleavage assays were performed using the co-transfection assay described previously. We see that the STING of naked mole rat and desert woodrat is clearly cleaved by the DENV2 protease, in that the cleavage product is evident ([Figure 6B](#fig6){ref-type="fig"}). We do not see a cleavage product for chinchilla STING, even under long exposure, but we do see the STING band disappear. It's possible that, in this case, the cleavage product is too unstable to be detected. The identification of animal models encoding STING proteins that can be cleaved by dengue might be important; the advantage to using such species as models is that, unlike in STING knockout mice, the STING pathway would be intact in these animals.

Discussion {#s3}
==========

In humans cells, sylvatic and human dengue viruses replicate similarly ([@bib89], [@bib88]). These results have been interpreted to mean that there is little or no adaptive barrier for the emergence of sylvatic dengue viruses into human populations. Our data agree with, but add a new element to, this model. Rather than there being critical differences between human and sylvatic viruses, our data suggest that there are critical differences between human and monkey hosts. This difference tracks, at least in part, to STING, revealing one way in which dengue viruses are reaching higher titers in humans than in monkey models. Collectively our data suggest that all dengue viruses cleave human STING, but not the versions of STING found in most other mammals. We have used the STING proteins of closely related primate species to map the determinant of cleavage in STING. We find that the viral protease is recognizing (i.e. cutting or binding) residues around positions 78/79 of STING. We show that an 'RG' motif at these two residues is necessary and sufficient for cleavage by the proteases of all four human epidemic dengue viruses, and one sylvatic dengue virus. Yet, only some apes and three rodent species, out of all of the mammalian STING sequences in Genbank, encode an RG at positions 78/79.

Why do dengue viruses universally cleave human but not monkey STING? It's possible that what we have uncovered is a brilliant method for balancing alternate host species, one of which is dense and abundant (humans), versus others that are spare and exist in smaller populations (primates in nature). In this scenario, dengue viruses have evolved to suppress innate immunity in humans in order to increase viral titers and spread, even though this trait comes at the cost of increased pathogenicity in some individuals. This might be a good strategy in our abundant and dense host population, where the fitness cost of severe disease in a fraction of individuals would be outweighed by excellent spread. Remarkably, though, dengue viruses have achieved this by evolving to recognize a portion of human STING that is not conserved in the STING of the wild and more rare animals that serve as their sustaining reservoir in nature, allowing the viruses to maintain decreased pathogenicity in these species. The evolution of the viral proteases to cleave human STING and simultaneously to avoid cleavage of monkey STING would be expected to reduce virus titers in monkeys, as the interferon pathway would be at least partially enabled. This may be beneficial for many reasons, one of which is that the production of a low-level innate immune response may allow the virus to replicate in reservoir host species without inducing high titers and strong adaptive immune responses. Alternately, a second possibility is that sylvatic dengue viruses do cleave the STING of monkeys, but that the sylvatic virus (DakAr-141069) that we tested is not representative. However, we find this unlikely. Because DENV1-4 also cannot cleave monkey STING, and all derive from the sylvatic reservoir, this supports the finding that sylvatic viruses do not cleave monkey STING. Third, a final possibility is that apes are critical reservoirs for dengue viruses in nature. Gorillas encode 'RG' at 78/79 and are found in Africa, while orangutans and gibbons are found in Asia and also encode the correct cleavage motif for the dengue virus protease. In fact, wild orangutans have previously been found to have neutralizing antibodies against dengue virus ([@bib94]). While apes could be playing a role as sylvatic hosts, the highly endangered and rare status of most apes makes it hard to believe that they are playing a major role in sustaining sylvatic dengue virus currently ([@bib28]; [@bib91]).

The specific primate species that serve as the sustaining reservoir for sylvatic dengue viruses in nature are unknown ([@bib86]). Various Old World monkey species in both Asia and Africa are suspected hosts ([@bib86]; [@bib69]; [@bib20]). For instance, sylvatic dengue viruses have been isolated directly from macaques (*Macaca fascicularis)* and leaf monkeys (*Presbytis obscura*) that were placed as sentinels in forest canopies ([@bib74]). Other primates have been shown to have antibodies to dengue virus, including macaques (*Macaca fascicularis* and *Macaca nemestrina*), leaf monkeys (*Presbytis cristata*) ([@bib73]), African green monkeys (*Chlorocebus sabaeus*) ([@bib20]), and one ape species, the Bornean orangutan (*Pongo pygmaeus*) ([@bib94]). But these results are not definitive due to the cross-reactivity of antibodies directed against various flaviviruses ([@bib12]; [@bib85]; [@bib45]), and the possibility that some primates might be accidental, rather than sustaining reservoir hosts ([@bib86]). Instead of being directly isolated from primates, most sylvatic dengue viruses have been obtained from forest mosquitoes ([@bib20]; [@bib74]), or from humans that contracted the virus in the forest ([@bib66]; [@bib14]; [@bib26]). Therefore, there are many deficiencies in our understanding of the natural reservoir for dengue viruses. Interestingly, though, we have not identified any monkey species with an 'RG' at positions 78/79 in STING. Our results would indicate that dengue viruses, in general, cannot cleave the STING of monkey hosts. Our data suggests that even a sylvatic dengue virus, which we find targets the same residues in STING, would not be able to cleave STING of monkeys.

There are also implications of these findings to our understanding of dengue virus model organisms. If dengue proteases do not cleave most nonhuman forms of STING, this may at least partially explain why it has been so difficult to model dengue infection in immune-competent animals. Nonhuman primates infected with dengue virus generally don't develop clinical signs of disease, consistent with enhanced control of the virus compared to humans ([@bib15]). In fact, when human dengue viruses have been observed to replicate robustly in primate cell lines, these experiments have typically been done in cells such as Vero ([@bib88]; [@bib71]; [@bib87]) which are deficient in the type I interferon response ([@bib60]; [@bib19]). Human dengue viruses also cannot cleave mouse STING (([@bib3]; [@bib96]) and herein), consistent with the heightened control of this virus in mice as well ([@bib15]). Dengue virus will replicate to high titers in mice lacking key genes important for the interferon response, but for many reasons it is desirable to develop animal models in immune competent hosts ([@bib15]). STING now adds to a growing list of host proteins that regulate viral infection differently even in closely related host species (for example, \[[@bib81]; [@bib44]; [@bib72]; [@bib41]; [@bib50]; [@bib18]; [@bib82]; [@bib17]; [@bib58]; [@bib35]; [@bib67]; [@bib61]; [@bib23]; [@bib46]; [@bib53]; [@bib75]; [@bib51]\]). The identification of such genes is critical to our understanding of viral adaptation during host switching, and to the development of animal models in which to study human viruses.

It is possible that the identification of small mammals that have a cleavage-susceptible STING would facilitate the development of better animal models for studying dengue virus. Our work suggests the identity of three such species: the naked mole rat, the common chinchilla, and the desert woodrat. All three of these small rodents are already used as animal models in biomedical research, and the genomes of all three have been sequenced ([@bib40]; [@bib57]; [@bib78]; [@bib13]; [@bib80]). These species could be superior to STING knockout mice, in that the STING pathway would be intact and the cleavage of STING by the virus would be naturally modeled rather than just bypassed. These species may also be superior to future models where mouse (*Mus musculus*) STING would be replaced with human STING in transgenic animals. In this case, it is unknown if human STING would perform all of its functions the same in mouse as it does in humans. The advantage of using a rodent model with a STING that is naturally susceptible to dengue virus cleavage would be that the STING pathways would all be fully functional and intact. It is important to point out that, in addition to cleaving STING, dengue viruses modulate the interferon response in other ways as well. For instance, dengue viruses also bypass the type I interferon response by binding and degrading host STAT2 via the viral NS5 protein ([@bib5]; [@bib39]; [@bib48]; [@bib9]). Ideally, human dengue viruses would also be able to bind and degrade STAT2 in newly developed models, as they do in humans. Further, dengue viruses neutralize both the type I and type II interferon responses in other ways as well ([@bib64]; [@bib79]; [@bib2]; [@bib1]). Other known host-virus interactions would also need to be characterized in any potential new model organism.

It is notable that chimpanzees and bonobos encode STINGs that are resistant to cleavage, while STINGs of all other apes are susceptible. These two species differ from other apes in encoding a 'WG' at 78/79 of STING rather than the 'RG' encoded by all other apes ([Figure 6](#fig6){ref-type="fig"}). Remarkably, it was previously found that the 'W' at position 78, destroying the dengue cleavage determinant, was fixed by positive natural selection in wild chimpanzee populations ([@bib56]). Chimpanzees are not one of the suspected natural reservoirs of dengue virus, but chimpanzee ranges do co-occur with known human outbreaks and with sylvatic cycles ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). One model is that, as dengue virus spread through Africa, a SNP in chimpanzee STING (or the STING of the chimpanzee/bonobo ancestor) at position 78 started to experience strong selection because it provided protection against cleavage by dengue viruses. This would have driven a selective sweep in chimpanzee populations, causing this species to become less susceptible to viral infection. It has previously been proposed that evolutionary pressure imposed by flavivirus proteases can drive selection at cleavage sites. For examples, the hepatitis C protease cleaves MAVS, another host signaling protein in the interferon induction cascade ([@bib43]; [@bib52]). MAVS has experienced positive selection at a residue in the cleavage site for the hepatitis C virus protease ([@bib61]). The authors of this study speculated that ancient viruses may have exerted selective pressure on primate genomes to acquire mutations in the cleavage site.

Like other viruses, dengue viruses remodel their host cellular environment in numerous ways, including the cleavage of STING and degradation of STAT2. Using the rich information that exists on how dengue viruses accomplish this, the genetic susceptibility of both suspected reservoir hosts, and potential new animal models, can be systematically assessed. Characterizing how host-virus interactions play out uniquely in different host species will help us to understand dengue virus in critical ways. For instance, it will reveal how dengue viruses do (or do not) need to evolve their genomes as they transmit to humans from nonhuman primates in nature. Also, understanding the genetics of host tropism will help identify better laboratory animals that can be used to study dengue virus pathogenesis and to develop drugs and vaccines.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------
  Reagent type (species)\      Designation                Source or\      Identifiers            Additional information
  or resource                                             reference                              
  ---------------------------- -------------------------- --------------- ---------------------- ------------------------------------
  gene (Homo sapiens)          STING; TMEM173             NA              GENBANK:NM_198282      GENBANK:MF622062

  gene (Homo sapiens)          STING; TMEM173             this study                             GENBANK:MF622062

  gene (Pan troglodytes)       STING; TMEM173             NA              GENBANK:XM_016953921   

  gene (Pan paniscus)          STING; TMEM173             this study                             GENBANK:MF616339

  gene (Gorilla gorilla)       STING; TMEM173             NA              GENBANK:XM_0040426     

  gene (Pongo abelii)          STING; TMEM173             NA              GENBANK:XM_002815952   

  gene (Hylobates agilis)      STING; TMEM173             this study                             GENBANK:MF616342

  gene (Symphalangus\          STING; TMEM173             this study                             GENBANK:MF616343
  syndactylus)                                                                                   

  gene (Nomascus\              STING; TMEM173             this study                             GENBANK:MF616344
  leucogenys)                                                                                    

  gene (Hylobates lar)         STING; TMEM173             this study                             GENBANK:MF616341

  gene (Rhinopithecus\         STING; TMEM173             NA              GENBANK:XM_010388119   
  roxellana)                                                                                     

  gene (Rhinopithecus\         STING; TMEM173             NA              GENBANK:XM_017895026   
  bieti)                                                                                         

  gene (Trachypithecus\        STING; TMEM173             this study                             GENBANK:MF616352
  francoisi)                                                                                     

  gene (Colobus\               STING; TMEM173             this study                             GENBANK:MF616351
  guereza)                                                                                       

  gene (Chlorocebus\           STING; TMEM173             NA              GENBANK:XM_008014636   
  sabaeus)                                                                                       

  gene (Cercopithecus\         STING; TMEM173             this study                             GENBANK:MF616350
  wolfi)                                                                                         

  gene (Miopithecus\           STING; TMEM173             this study                             GENBANK:MF616349
  talapoin)                                                                                      

  gene (Macaca\                STING; TMEM173             NA              GENBANK:XM_011716377   
  nemestrina)                                                                                    

  gene (Macaca mulatta)        STING; TMEM173             NA              GENBANK:XM_015141010   

  gene (Macaca mulatta)        STING; TMEM173             this study                             GENBANK:MF622060

  gene (Macaca\                STING; TMEM173             this study                             GENBANK:MF616346
  fascicularis)                                                                                  

  gene (Papio papio)           STING; TMEM173             this study                             GENBANK:MF616348

  gene (Lophocebus\            STING; TMEM173             this study                             GENBANK:MF616347
  albigena)                                                                                      

  gene (Cercocebus atys)       STING; TMEM173             NA              GENBANK:XM_012090448   

  gene (Mandrillus\            STING; TMEM173             NA              GENBANK:XM_011997224   
  leucophaeus)                                                                                   

  gene (Aloutta sara)          STING; TMEM173             this study                             GENBANK:MF616355

  gene (Callicebus\            STING; TMEM173             this study                             GENBANK:MF616354
  cupreus)                                                                                       

  gene (Callithrix jacchus)    STING; TMEM173             NA              GENBANK:XM_00898588    

  gene (Callithrix jacchus)    STING; TMEM173             this study                             GENBANK:MF622061

  gene (Cebus capucinus\       STING; TMEM173             NA              GENBANK:XM_017536735   
  imitator)                                                                                      

  gene (Samiri boliviensis)    STING; TMEM173             NA              GENBANK:XM_003933913   

  gene (Saimiri sciureus)      STING; TMEM173             this study                             GENBANK:MF616353

  gene (Mus musculus)          STING; TMEM173             NA              GENBANK:NM_001289591   

  gene (Sus scrofa)            STING; TMEM173             NA              GENBANK:XP_005661761   

  gene (Heterocephalus\                                   NA              GENBANK:JAO02071       
  glaber)                                                                                        

  gene (Chinchilla lanigera)                              NA              GENBANK:XP_005382124   

  gene (Neotoma lepida)                                   NA              GENBANK:OBS58238       

  gene (Dengue viurs 2)        NS2B3                      NA              GENBANK:M29095         

  cell line (Homo sapiens)     293T cells                 ATCC            CRL-3216               

  cell line (Homo sapiens)     A549 cells                 ATCC            CCL-185                

  antibody                     Rat anti-HA-HRP (3F10)     Sigma           11867423001            

  antibody                     Mouse anti-Flag (M2)       Sigma           F3165                  

  antibody                     Rabbit anti-pIRF3          abcam           ab76493                

  antibody                     Rabbit anti-IRF3           Santa Cruz\     sc-9082                
                                                          Biotech                                

  antibody                     Rabbit anti-GAPDH          Cell\           14C10                  
                                                          Signaling                              

  antibody                     Rabbit anti-STING          abcam           ab92605                

  antibody                     Mouse anti-Actin (C4)      Santa Cruz\     Sc47778                
                                                          Biotech                                

  recombinant DNA reagent      DENV2 NS2B3 WT\            PMID: 1642612                          Progenitors: DENV2 NGC\
                               (plasmid)                                                         (GENBANK:M29095), pCR3.1

  recombinant DNA reagent      DENV2 NS2B3\               PMID: 1642612                          Progenitors: DENV2 NS2B3 WT\
                               S135A (plasmid)                                                   pCR3.1 plasmid, SDM

  recombinant DNA reagent      DENV1 (Hawaii)\            this paper                             Progenitors: World Reference\
                               cDNA                                                              Center for Emerging Viruses\
                                                                                                 and Arboviruses (WRCEVA)\
                                                                                                 Catalog number NR-4287

  recombinant DNA reagent      DENV2 (New\                this paper                             Progenitors: World Reference\
                               Guinea C) cDNA                                                    Center for Emerging Viruses\
                                                                                                 and Arboviruses (WRCEVA)\
                                                                                                 Catalog number NR-4288

  recombinant DNA reagent      DENV3 (Philippines/\       this paper                             Progenitors: World Reference\
                               H87/1956) cDNA                                                    Center for Emerging Viruses and\
                                                                                                 Arboviruses (WRCEVA)\
                                                                                                 Catalog number NR-2771

  recombinant DNA reagent      DENV4 (H241) cDNA          this paper                             Progenitors: World Reference\
                                                                                                 Center for Emerging Viruses\
                                                                                                 and Arboviruses (WRCEVA)\
                                                                                                 Catalog number NR-4289

  recombinant DNA reagent      DENV1 (Hawaii)\            this paper                             Progenitors: DENV1 (Hawaii)\
                               NS2B3 WT (plasmid)                                                cDNA, pCR3.1

  recombinant DNA reagent      DENV2 (New Guinea C)\      this paper                             Progenitors: DENV2 (New Guinea C)\
                               NS2B3 WT (plasmid)                                                cDNA, pCR3.1

  recombinant DNA reagent      DENV3 (Philippines/\       this paper                             Progenitors: DENV3\
                               H87/1956) NS2B3\                                                  (Philippines/H87/1956)\
                               WT (plasmid)                                                      cDNA, pCR3.1

  recombinant DNA reagent      DENV4 (H241)\              this paper                             Progenitors: DENV4 (H241)\
                               NS2B3 WT (plasmid)                                                cDNA, pCR3.1

  recombinant DNA reagent      Sylvatic (DakAr-141069)\   this paper                             Progenitors: DakAr-141069 NS2B3\
                               Dengue NS2B3\                                                     sequence (GenBank EF105389)
                               Protease (WT)                                                     

  recombinant DNA reagent      Sylvatic (DakAr-141069)\   this paper                             Progenitors: Sylvatic\
                               Dengue NS2B3\                                                     (DakAr-141069) Dengue NS2B3\
                               Protease (S135A)                                                  Protease (WT) SDM product

  recombinant DNA reagent      human cDNA                 this paper                             Progenitors: A549 cell line\
                                                                                                 (ATCC CCL-185)

  recombinant DNA reagent      chimpanzee cDNA            this paper                             Progenitors: Coriell PR00748

  recombinant DNA reagent      rhesus\                    this paper                             Progenitors: Mm265-95
                               macaque cDNA                                                      

  recombinant DNA reagent      marmoset cDNA              this paper                             Progenitors: Coriell PR07404

  recombinant DNA reagent      mouse cDNA                 this paper                             Progenitors: RNA extracted\
                                                                                                 from mouse liver

  recombinant DNA reagent      human\                     this paper                             Progenitors: human cDNA,\
                               STING-HA (plasmid)                                                pcDNA3.1 plasmid

  recombinant DNA reagent      human\                     this paper                             Progenitors: human cDNA,\
                               STING-HA (plasmid)                                                pLPCX plasmid

  recombinant DNA reagent      human\                     this paper                             Progenitors: human STING-HA\
                               STING(R78W)-HA\                                                   pcDNA3.1 SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      human\                     this paper                             Progenitors: human STING-HA\
                               STING(R78W)-HA\                                                   pLPCX SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      human\                     this paper                             Progenitors: human STING-HA\
                               STING(R79D)-HA\                                                   pcDNA3.1 SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      human\                     this paper                             Progenitors: human STING-HA\
                               STING(R78Q)-HA\                                                   pcDNA3.1 SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      chimpanzee\                this paper                             Progenitors: chimpanzee cDNA,\
                               STING-HA\                                                         pcDNA3.1 plasmid
                               (plasmid)                                                         

  recombinant DNA reagent      chimpanzee\                this paper                             Progenitors: chimpanzee cDNA,\
                               STING-HA (plasmid)                                                pLPCX plasmid

  recombinant DNA reagent      chimpanzee\                this paper                             Progenitors: chimpanzee\
                               STING(W78R)-HA\                                                   STING-HA pcDNA3.1 SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      chimpanzee\                this paper                             Progenitors: chimpanzee\
                               STING(W78R)-HA\                                                   STING-HA pLPCX SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      rhesus macaque\            this paper                             Progenitors: rhesus macaque\
                               STING-HA (plasmid)                                                cDNA, pcDNA3.1 plasmid

  recombinant DNA reagent      rhesus macaque\            this paper                             Progenitors: rhesus macaque\
                               STING(D79G)-HA\                                                   STING-HA pcDNA3.1 SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      marmoset STING-HA\         this paper                             Progenitors: marmoset\
                               (plasmid)                                                         cDNA, pcDNA3.1 plasmid

  recombinant DNA reagent      marmoset\                  this paper                             Progenitors: marmoset\
                               STING(Q78R)-HA\                                                   STING-HA pcDNA3.1 SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      mouse STING-HA\            this paper                             Progenitors: mouse cDNA,\
                               (plasmid)                                                         pcDNA3.1 plasmid

  recombinant DNA reagent      mouse\                     this paper                             Progenitors: mouse STING-HA\
                               STING(Q78R)-HA\                                                   pcDNA3.1 SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      mouse\                     this paper                             Progenitors: mouse STING-HA\
                               STING(93LRRG96)-HA\                                               pcDNA3.1 SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      human STING-3xFLAG\        this paper                             Progenitors: human cDNA,\
                               (plasmid)                                                         pLPCX plasmid

  recombinant DNA reagent      human\                     this paper                             Progenitors: human\
                               STING(R78W)-3xFLAG\                                               STING-3xFLAG pLPCX SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      human\                     this paper                             Progenitors: human\
                               STING(G230A)-3xFLAG\                                              STING-3xFLAG pLPCX SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      human STING\               this paper                             Progenitors: human\
                               (R78W, G230A)-3xFLAG\                                             STING-3xFLAG pLPCX SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      chimpanzee\                this paper                             Progenitors: chimpanzee\
                               STING-3xFLAG\                                                     cDNA, pLPCX plasmid
                               (plasmid)                                                         

  recombinant DNA reagent      chimpanzee STING\          this paper                             Progenitors: chimpanzee\
                               (W78R)-3xFLAG\                                                    STING-3xFLAG pLPCX SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      chimpanzee\                this paper                             Progenitors: chimpanzee\
                               STING(A230G)-3xFLAG\                                              STING-3xFLAG pLPCX SDM product
                               (plasmid)                                                         

  recombinant DNA reagent      chimpanzee\                this paper                             Progenitors: chimpanzee\
                               STING(W78R,\                                                      STING-3xFLAG pLPCX SDM product
                               A230G)-3xFLAG\                                                    
                               (plasmid)                                                         

  recombinant DNA reagent      IFN-ß1-luc (plasmid)       PMID:\                                 
                                                          21512573                               

  recombinant DNA reagent      pRL-CMV (plasmid)          Promega:\                              Progenitors: pRL-null
                                                          AF025843                               

  commercial assay or kit      Dual-Glo Luciferase\       Promega         Cat\#E2920             
                               Assay System                                                      

  commercial assay or kit      Superscript III\           Thermo\         Cat\#18080051          
                               First-Strand\              Scientific                             
                               Synthesis System                                                  

  software, algorithm          MEGA7                                                             <http://www.megasoftware.net/>

  software, algorithm          ImageJ version 1.43u                                              <http://rsb.info.nih.gov/ij>

  software, algorithm          Python 2.7.11                                                     <https://www.python.org>

  software, algorithm          Sequencher                                                        <https://www.genecodes.com>
  -----------------------------------------------------------------------------------------------------------------------------------

Plasmids {#s4-1}
--------

DENV2 NS2B3, expressed from the pCR3.1 plasmid, was a gift from Yi-Ling Lin. This plasmid, and all DENV1-4 protease-expressing plasmids described below, include a 3x FLAG tag at the C-terminus of NS3. For the experiment where proteases from human dengue viruses DENV1-4 are compared, primers were designed at the 5' end of NS2B

(DENV1: taagcaAAGCTTcaccATGAGTTGGCCCCTC,

DENV2: taagcaAAGCTTcaccATGAGCTGGCCACTAAATGA,

DENV3: taagcaAAGCTTcaccATGAGCTGGCCACTG,

DENV4: taagcaAAGCTTcaccATGTCTTGGCCCCTTAAC) and the 3' end of NS3

(DENV1: TGCTTAgtcgacaTCTTCTTCCTGCTGCAAACTCTTTAAACTC,

DENV2: TGCTTAgtcgacaCTTTCTTCCAGCTGCAAACTCCTTG,

DENV3: TGCTTAgtcgacaCTTTCTGCCAGCTGCAAAATCCTTG,

DENV4: TGCTTAgtcgacaCTTTCTTCCACTGGCAAACTCCTTG) to amplify the NS2B + NS3 genomic region in one fragment. In this experiment, the protease from DENV2 was re-cloned so that the structure of the four protease clones was identical in all four cases. The PCR templates were cDNAs created from RNA obtained through the World Reference Center for Emerging Viruses and Arboviruses (WRCEVA) (Cat\# NR-32847). DENV1 (Hawaii, NR-4287), DENV2 (New Guinea C, NR-4288), DENV3 (Philippines/H87/1956, NR-2771), and DENV4 (H241, NR-4289). The PCR products, and the plasmid containing the DENV2 protease mentioned above (gift from Yi-Ling Lin), were both digested with HindIII and Sal1. The PCR products were ligated into this plasmid and transformed into DH5α chemically competent *E.coli*. The sylvatic NS2B3 (DakAr141069) was synthesized (without an epitope tag) using the sequence information deposited on NCBI (Genbank accession EF105389). STING genes used for functional analysis were amplified from cDNA libraries constructed from the following cell lines: human (A549), chimpanzee/bonobo (STING sequence identical for these two species, clone amplified from Coriell, PR00748), rhesus macaque (Mm265-95, a gift from Welkin Johnson), marmoset (Coriell, PR07404), and mouse (generated from RNA extracted from whole liver). Either an HA or 3xFlag tag were engineered onto the 3\' end of the gene sequences, separated from the coding sequence by a 3xGlycine-Alanine (GAGAGA) linker region (nucleotide sequence = GGTGCTGGTGCTGGTGCT). These sequences were cloned into the pcDNA3.1 expression vector with a 5\' Kozak sequence (GCCACC). Rodent STING constructs were synthesized (Quintarabio) to include a Kozak sequence, C-terminal HA-tag, and flanking linkers that were used for Gibson cloning into the pLPCX mammalian expression plasmid.

STING cleavage assays {#s4-2}
---------------------

293 T cells (mycoplasma negative) were grown at 37°C in DMEM supplemented with 10% FBS, Pen/Strep, and L-glutamine. 24 hr prior to transfection, cells were plated at a density of 4.5 × 10^5^ cells per well in a 12-well dish in antibiotic free media. Wells were transfected with 800 ng plasmid encoding STING and 800 ng plasmid encoding NS2B3 using TransIT 293 reagent (Mirus MIR 2704). For most experiments ([Figures 1B](#fig1){ref-type="fig"}, [3B](#fig3){ref-type="fig"}, [5A and B](#fig5){ref-type="fig"}), cells were treated with 10uM MG132 for 8 hr prior to harvesting for western blot.

Western blotting {#s4-3}
----------------

Cells were lysed in RIPA buffer supplemented with protease inhibitor (Roche, 4693159001). Protein concentration was calculated using the Bradford method. 10% 37.5:1 Acrylamide/Bisacrylamide gels were used to run 30 ug of whole cell lysate for each sample. Protein was transferred overnight at 30 volts onto a polyvinyl membrane. Blocking was performed with a 10% milk solution in tris-buffered saline supplemented with 0.1% TWEEN20. Primary antibodies used were used against HA (3f10 clone Sigma 11867423001), Flag (M2 clone Sigma F3165), GAPDH (CellSignaling 14C10), STING (Abcam 92605), actin (Santa Cruz Biotech Sc47778), and dengue virus NS3 (mouse polyclonal antibody raised against purified full-length NS3 from dengue 2 strain 16681 \[[@bib32]\]). Secondary antibodies used were goat-anti-mouse-HRP (Thermo 62--6520) and goat-anti-rabbit (Thermo 65--6120). Blots were developed using ECL Prime (Amersham RPN2232) and imaged using ImagQuant LAS 4000 (Amersham 28-9558-10).

CRISPR-Cas9 mediated disruption of STING, and stable re-complementation with primate orthologs {#s4-4}
----------------------------------------------------------------------------------------------

A549 cells (mycoplasma negative) were transfected with the pSPCAS9(BB)-P2A-eGFP (PX458) with the guide RNA sequence 5' AGAGCACACTCTCCGGTACC 3'. GFP-positive cells were single-cell sorted into a 96-well dish and colonies were grown up. Cloned A549 cells were screened for homozygous mutations that disrupted the coding sequence of STING as follows. 10,000 cells were used to prep whole genomic DNA. The region surrounding the guide RNA was amplified using the following primers: 5' GTCCCCAAGGGTTCTTGGTT 3' and 5' AACCAGTCCCACTCCCAGTA 3'. Amplified genomic DNA was Sanger sequenced to determine the nature of the CRISPR-CAS9-mediated genomic disruption. A cell line with confirmed homozygous disruption of STING ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}) was then re-complemented with primate orthologs of STING. Four different C-terminally HA-tagged versions of STING were cloned into the pLPCX retroviral vector: wildtype human STING, R78W human STING, wildtype chimpanzee STING, and W78R chimpanzee STING. These were packaged into retroviral particles by cotransfecting into 293T cells (mycoplasma negative) each pLPCX-STING construct with plasmids expressing NB-tropic murine leukemia virus (MLV) Gag-Pol and VSV-G. As a control, we also made virus to complement with an empty pLPCX vector. Supernatants were collected and used to transduce 10\^5 A549 cells in the presence of 10 ug/mL polybrene. 24 hr post transduction, cells were selected in 0.75 ug/mL puromycin.

Immunofluorescence {#s4-5}
------------------

24 hr after plating, cells were fixed with 4% paraformaldehyde and permeabilized with 1% TritonX100 in PBS. Blocking was performed with 3% BSA solution in PBS. Primary antibodies used were rabbit-anti-GRP78 (BiP) (Abcam ab21685) and mouse-anti-HA (clone 16B12 abcam ab130275). Secondary antibodies used were donkey-anti-rabbit conjugated to AlexaFluor594 (Invitrogen A21207) and donkey-anti-mouse conjugated to AlexaFluor488 (Invitrogen A21202). Cells were mounted using VECTASHIELD hardset mounting media (VectorLabs H-1400).

Dengue infection assays {#s4-6}
-----------------------

The indicated STING knockout and re-complemented cell lines were plated out in F-12K media with 10% FBS, after 24 hr the cells were counted. An MOI of 0.3 was calculated for each well and dengue virus 2 (16681) was allowed to attach to cells for 1 hr at room temperature. Unattached virus was then removed from cells, 2%serum in F-12K media was added to cells and they were maintained at 37°C with 5% CO~2~. After 24 and 48 hr the virus supernatant was removed for downstream titration on BHK21 cells. At the same time, cells were removed for downstream western blotting.

Sequencing STING from other primate species {#s4-7}
-------------------------------------------

The following STING sequences were collected from GenBank: chimpanzee (*Pan troglodytes*, XM_016953921.1), gorilla (*Gorilla gorilla gorilla*, XM_004042612.1), Sumatran orangutan (*Pongo abelii*, XM_002815952.2), golden snub-nosed monkey (*Rhinopithecus roxellana*, XM_010388119.1), black snub-nosed monkey (*Rhinopithecus bieti*, XM_017895026.1), African green monkey (*Chlorocebus sabaeus*, XM_008014636.1), pigtail macaque (*Macaca nemestrina*, XM_011716377.1), rhesus macaque (*Macaca mulatta*, XM_015141010.1), sooty mangabey (*Cercocebus atys*, XM_012090448.1), drill (*Mandrillus leucophaeus*, XM_011997224.1), marmoset (*Callithrix jacchus*, XM_00898588.2), capuchin monkey (*Cebus capucinus imitator*, XM_017536735.1), black-capped squirrel monkey (*Saimiri boliviensis*, XP_003933962.1). The remaining STING gene sequences were obtained by direct sequencing of cDNA libraries produced from the following primary or immortalized primate fibroblast cell lines: Bonobo (*Pan* paniscus, Coriell PR00748), Bornean orangutan (*Pongo pygmaeus*, Coriell PR00650), white-handed gibbon (*Hylobates lar*, Coriell PR01131), agile gibbon (*Hylobates agilis*, Coriell PR00773), siamang (*Symphalagus syndactylus*, Coriell PR00722), white-cheeked gibbon (*Nomascus leucogenys*, Coriell PR01037), leaf monkey (*Trachypithecus francoisi*, Coriell PR01099), colobus monkey (*Colobus guereza*, Coriell PR00980), Wolf's guenon (*Cercopithecus wolfi*, Coriell PR01241), talapoin (*Miopithecus talapoin*, Coriell PR00716), crab-eating macaque (*Macaca fasicularis*, 103--06, gift from Welkin Johnson), olive baboon (*Papio anubis*, Coriell PR00978), grey-cheeked mangabey (*Lophocebus albigena*, Coriell PR01215), Bolivian red howler monkey (*Alouatta sara*, Coriell PR00708), red titi monkey (*Callicebus* (or *Plecturocebus*) *cupreus*, Coriell PR00793), common squirrel monkey (*Saimiri sciureus*, Coriell PR00603). Briefly, cells were grown in DMEM (Cellgro) supplemented with 15% FBS (Gibco) at 37°C and 5% CO2. RNA was extracted using the AllPrep DNA/RNA extraction kit (QIAGEN). cDNA libraries were generated using SuperScript III first strand synthesis kit (Invitrogen). PCR was performed using PCR SuperMix High Fidelity (Invitrogen). PCR products were directly sequenced. Each primate sequence was used as a query to search the human genome, and human STING gene was returned as the top hit. STING gene sequences generated in this study have been deposited in GenBank (accession numbers MF616339-MF616355).

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000002National Institutes of Health R01-GM-093086 to Sara L Sawyer.

-   http://dx.doi.org/10.13039/100000861Burroughs Wellcome Fund PATH to Sara L Sawyer.

-   http://dx.doi.org/10.13039/100000002National Institutes of Health F30-AI-112277 to Alex C Stabell.

-   http://dx.doi.org/10.13039/100000001National Science Foundation GRFP to Nicholas R Meyerson.

-   http://dx.doi.org/10.13039/100000861Burroughs Wellcome Fund PDEP to Nicholas R Meyerson.

We thank Kartik Chandran, Nels Elde, Emily Feldman, Maryska Kaczmarek, Michael Smallegan, Cody Warren, and Qing Yang for thoughtful comments on this study. This work was supported by National Institutes of Health grant R01-GM-093086 to SLS. ACS was supported by an M.D./Ph.D. training fellowship from the National Institutes of Health (F30-AI-112277). NRM was supported by a graduate fellowship from the National Science Foundation, and a PDEP award from the Burroughs Wellcome Fund. RCG and RP were supported by the department of Microbiology, Immunology and Pathology at CSU. SLS is a Burroughs Wellcome Investigator in the Pathogenesis of Infectious Disease.

Additional information {#s5}
======================

No competing interests declared.

Conceptualization, Formal analysis, Investigation, Methodology, Writing---original draft.

Validation, Investigation, Writing---review and editing.

Validation, Investigation, Methodology, Writing---review and editing.

Formal analysis, Investigation, Methodology.

Formal analysis, Investigation, Methodology.

Formal analysis, Supervision.

Validation, Investigation, Writing---review and editing.

Conceptualization, Data curation, Supervision, Funding acquisition, Writing---review and editing.

Additional files {#s6}
================

10.7554/eLife.31919.014

###### Alignment of primate STING proteins.

10.7554/eLife.31919.015

Major datasets {#s7}
--------------

The following dataset was generated:

Stabell A2018outbreak_mapping<http://dx.doi.org/10.5061/dryad.pm7ch>Available at Dryad Digital Repository under a CC0 Public Domain Dedication

The following previously published dataset was used:

Messina JPBrady OJPigott DMBrownstein JSHoen AGHay SI2014Dengue_Occurrence_12122013.xlsx<https://figshare.com/articles/Dengue_Occurrence_12122013.xlsx/1035043>Available at figshare under a CC0 Public Domain licence

10.7554/eLife.31919.021

Decision letter

Knipe

David M

Reviewing Editor

Harvard Medical School

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"Dengue viruses cleave STING in humans but not in their nonhuman primate reservoirs\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors and the evaluation has been overseen by Wenhui Li as the Senior Editor. The reviewers have opted to remain anonymous.

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

The reviewers all feel that this is an interesting manuscript examining the ability of the dengue virus protease to cleave STING in a species-specific manner to evade induction of IFN responses. Most of the primates, including those that are a reservoir for DENV, have a STING unable to be cleaved by DENV. You have identified that it is due to a single amino acid change, which you interpret to be a new cleavage site in STING of the dengue protease. Before the manuscript is considered further for *eLife*, it is essential to provide biochemical evidence that this is truly the authentic cleavage site. Furthermore, your speculation about the evolution of the ability of the dengue protease to cleave STING is interesting, but the reviewers feel that alternative models need to be considered in the manuscript.

Essential revisions:

Reviewer \#1:

This manuscript provides interesting results showing that the dengue virus infection can promote the cleavage of human STING and certain ape STING molecules but not many of the other primate STINGs. The research identified the human sequence needed for cleavage as 78RG79, which was also found in the ape proteins. Alteration of primate molecules to RG also allowed cleavage, and the authors conclude that this is the cleavage site. The results are very important in understanding the ability of dengue virus to infect humans and different non-human primate species.

The conclusion that they have identified a new cleavage site seems to be premature in the absence of any biochemical evidence. The authors need to provide biochemical evidence for cleavage at this site or alter their conclusions to state that they have identified sequences that are required.

Second, they speculate in the abstract and elsewhere that \"dengue viruses have evolved to fine-tune their pathogenicity in primates, but not yet in humans.\" I understand the evolution of a parasite to cause limited pathogenicity in its host to allow host survival, but where did the ability to cleave human STING come from? Was this from infection of an as yet unidentified species or did it evolve with infection of humans? This seems to be a very incomplete model.

Reviewer \#2:

This is an interesting manuscript that investigates in more detail the ability of the protease of DENV to cleave STING in a species-specific manner to evade induction of IFN responses. The authors find that most of the primates, including those that are a reservoir for DENV, have a STING unable to be cleaved by DENV. They found that this is due to a single amino acid change, most likely representing the cleavage site in STING of the dengue protease. In general, the data are consistent with this conclusion. However, some of the conclusions of the authors are too farfetched and they should be tempered.

1\) The authors are likely right in the cleavage sequence of STING, as one single amino acid change make human STING not cleaved and primate or mouse STING cleaved. However, there is always the possibility that this sequence participates in recognition by the protease and that cleavage occurs somewhere else. In the absence of direct evidence of the cleavage site, the authors should refer to this sequence as required for cleavage, but they cannot exclude that cleavage occurs at a different site.

2\) The experiments in [Figure 3](#fig3){ref-type="fig"} clearly show that a single amino acid at STING determines the efficiency of inhibition of DENV by STING. Not shown in this figure is the number of DENV infected cells. This is important, as the authors did not see differences in levels of STING, which most likely indicate that the majority of the cells are not infected and therefore, that STING is not cleaved in most of the cells due to the lack of infection. In order to proof that STING is cleaved in DENV infected cells, the authors should sort DENV infected versus non-infected cells and determine the amount of STING in both populations as compared with a control host protein.

3\) The speculation of the authors: \"We propose that dengue viruses have evolved to fine-tune their pathogenicity in their monkey reservoir hosts, but not yet humans. Reduced viral pathogenicity within reservoir hosts is predicted to be beneficial to both host and virus\" does not make sense. This will mean that the protease of DENV just by chance happened to cleave human STING, which also just by chance happened to be a major viral sensor. An alternative most likely explanation is that humans are since many thousands of years the main host for propagation of dengue virus, and therefore, the protease of DENV has evolved to cleave STING of the main host, humans, sacrificing the ability to cleave STING in primates, which are minor hosts, and therefore contribute less to the overall burden of dengue virus in nature. In other words, between two DENV, one cleaving human STING and the other cleaving primate STING, the one cleaving human STING has a competitive advantage over the one cleaving primate STING, as the virus has been mainly adapted to human and human mosquitoes, and primates might now be spillover reservoirs, but not main drivers of DENV evolution.

Reviewer \#3:

It has been demonstrated that the DENV protease can cleave Human STING. Using an evolution-guided approach, the authors determine the ability of the DENV protease to cleave STING varies across species including primates due to sequence differences at amino acid positions 78 and 79. This finding is significant because it answers the long-standing question of why dengue does not replicate to high titers and display pathology similar to what is observed during human infection in primate models. I feel this is a thorough study, in particular, due to the use of genetic complementation, and the various STING orthologs and DENV (1-4) proteases assayed.

Some modifications should be made to the text including the Title.

10.7554/eLife.31919.022

Author response

> Summary:
>
> The reviewers all feel that this is an interesting manuscript examining the ability of the dengue virus protease to cleave STING in a species-specific manner to evade induction of IFN responses. Most of the primates, including those that are a reservoir for DENV, have a STING unable to be cleaved by DENV. You have identified that it is due to a single amino acid change, which you interpret to be a new cleavage site in STING of the dengue protease. Before the manuscript is considered further for eLife, it is essential to provide biochemical evidence that this is truly the authentic cleavage site. Furthermore, your speculation about the evolution of the ability of the dengue protease to cleave STING is interesting, but the reviewers feel that alternative models need to be considered in the manuscript.
>
> Essential revisions:

Regarding the evolutionary model put forward, we have now highlighted the evolutionary model suggested by the reviewers, which we agree is more likely.

To address the location of the cleavage site, we have now immuno-precipitated the cleaved form of STING and performed mass spectrometry experiments. To do this experiment, we recruited two new authors who are proteomics experts (Webb and Old). Despite multiple attempts at this, the experiment did not allow us to precisely pin down the cleavage site. We were able to find some new data in the published literature that indicates the cleavage site is very close to the location that we have mapped (based on the molecular weights of the liberated products on a gel), and we discuss that.

As a result, we have tempered our language throughout the document, and now refer to STING positions 78/79 as a cleavage determinant, rather than a cleavage site. This seems like it should be a satisfactory solution to the cleavage site issue, since reviewer 1 stated that we should "provide biochemical evidence for cleavage at this site or alter their conclusions to state that they have identified sequences that are required, "and reviewer 2 stated "in the absence of direct evidence of the cleavage site, the authors should refer to this sequence as required for cleavage." reviewer 3 did not comment on this issue.

With regards to one of the comments of reviewer \#2, who wanted "proof that STING is cleaved in DENV infected cells" we have now performed a new experiment showing the cleavage of STING during infection, which is shown in in the new [figure 3---figure supplement 1](#fig3s1){ref-type="fig"}.

> Reviewer \#1:
>
> This manuscript provides interesting results showing that the dengue virus infection can promote the cleavage of human STING and certain ape STING molecules but not many of the other primate STINGs. The research identified the human sequence needed for cleavage as 78RG79, which was also found in the ape proteins. Alteration of primate molecules to RG also allowed cleavage, and the authors conclude that this is the cleavage site. The results are very important in understanding the ability of dengue virus to infect humans and different non-human primate species.
>
> The conclusion that they have identified a new cleavage site seems to be premature in the absence of any biochemical evidence. The authors need to provide biochemical evidence for cleavage at this site or alter their conclusions to state that they have identified sequences that are required.

We agree. We now refer to this as a cleavage determinant rather than a cleavage site, and clearly state the limitations of our finding. Please see additional commentary on this point in the opening remarks to the editor above, describing efforts that we made to address this issue.

> Second, they speculate in the abstract and elsewhere that \"dengue viruses have evolved to fine-tune their pathogenicity in primates, but not yet in humans.\" I understand the evolution of a parasite to cause limited pathogenicity in its host to allow host survival, but where did the ability to cleave human STING come from? Was this from infection of an as yet unidentified species or did it evolve with infection of humans? This seems to be a very incomplete model.

We agree, and now highlight a better model. In the Discussion section we now state:

"Why do dengue viruses universally cleave human but not monkey STING? It's possible that what we have uncovered is a brilliant method for balancing alternate host species, one of which is dense and abundant (humans), versus others that are spare and exist in smaller populations (primates in nature). In this scenario, dengue viruses have evolved to suppress innate immunity in humans in order to increase viral titers and spread, even though this trait comes at the cost of increased pathogenicity in some individuals. This might be a good strategy in our abundant and dense host population, where the fitness cost of severe disease in a fraction of individuals would be outweighed by excellent spread. Remarkably, though, dengue viruses have achieved this by evolved to recognize a portion of human STING that is not conserved in the STING of the wild and more rare animals that serve as their sustaining reservoir in nature, allowing the viruses to maintain decreased pathogenicity in these species. The evolution of the viral proteases to cleave human STING and simultaneously to avoid cleavage of monkey STING would be expected to reduce virus titers in monkeys, as the interferon pathway would be at least partially enabled. This may be beneficial for many reasons, one of which is that the production of a low-level innate immune response may allow the virus to replicate in reservoir host species without inducing high titers and strong adaptive immune responses.

> Reviewer \#2:
>
> This is an interesting manuscript that investigates in more detail the ability of the protease of DENV to cleave STING in a species-specific manner to evade induction of IFN responses. The authors find that most of the primates, including those that are a reservoir for DENV, have a STING unable to be cleaved by DENV. They found that this is due to a single amino acid change, most likely representing the cleavage site in STING of the dengue protease. In general, the data are consistent with this conclusion. However, some of the conclusions of the authors are too farfetched and they should be tempered.
>
> 1\) The authors are likely right in the cleavage sequence of STING, as one single amino acid change make human STING not cleaved and primate or mouse STING cleaved. However, there is always the possibility that this sequence participates in recognition by the protease and that cleavage occurs somewhere else. In the absence of direct evidence of the cleavage site, the authors should refer to this sequence as required for cleavage, but they cannot exclude that cleavage occurs at a different site.

We agree, and we now refer to this as a cleavage determinant rather than a cleavage site, and clearly state the limitations of our finding. Please see additional commentary on this point in the opening remarks to the editor above, describing efforts that we made to address this issue.

> 2\) The experiments in [Figure 3](#fig3){ref-type="fig"} clearly show that a single amino acid at STING determines the efficiency of inhibition of DENV by STING. Not shown in this figure is the number of DENV infected cells. This is important, as the authors did not see differences in levels of STING, which most likely indicate that the majority of the cells are not infected and therefore, that STING is not cleaved in most of the cells due to the lack of infection. In order to proof that STING is cleaved in DENV infected cells, the authors should sort DENV infected versus non-infected cells and determine the amount of STING in both populations as compared with a control host protein.

We have now performed an additional experiment and included a new supplemental figure (new [figure 3---figure supplement 1](#fig3s1){ref-type="fig"}) showing the cleavage of STING in our cell lines during infection.

> 3\) The speculation of the authors: \"We propose that dengue viruses have evolved to fine-tune their pathogenicity in their monkey reservoir hosts, but not yet humans. Reduced viral pathogenicity within reservoir hosts is predicted to be beneficial to both host and virus\" does not make sense. This will mean that the protease of DENV just by chance happened to cleave human STING, which also just by chance happened to be a major viral sensor. An alternative most likely explanation is that humans are since many thousands of years the main host for propagation of dengue virus, and therefore, the protease of DENV has evolved to cleave STING of the main host, humans, sacrificing the ability to cleave STING in primates, which are minor hosts, and therefore contribute less to the overall burden of dengue virus in nature. In other words, between two DENV, one cleaving human STING and the other cleaving primate STING, the one cleaving human STING has a competitive advantage over the one cleaving primate STING, as the virus has been mainly adapted to human and human mosquitoes, and primates might now be spillover reservoirs, but not main drivers of DENV evolution.

We now highlight this model in the paper.

> Reviewer \#3:

*It has been demonstrated that the DENV protease can cleave Human STING. Using an evolution-guided approach, the authors determine the ability of the DENV protease to cleave STING varies across species including primates due to sequence differences at amino acid positions 78 and 79. This finding is significant because it answers the long-standing question of why dengue does not replicate to high titers and display pathology similar to what is observed during human infection in primate models. I feel this is a thorough study, in particular, due to the use of genetic complementation, and the various STING orthologs and DENV (1-4) proteases assayed.*

> Some modifications should be made to the text including the Title.

We have crafted a new title.
